338 related articles for article (PubMed ID: 17110167)
1. Blood purification therapy for sepsis.
Sakata H; Yonekawa M; Kawamura A
Transfus Apher Sci; 2006 Dec; 35(3):245-51. PubMed ID: 17110167
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin apheresis for sepsis.
Shimizu T; Endo Y; Tsuchihashi H; Akabori H; Yamamoto H; Tani T
Transfus Apher Sci; 2006 Dec; 35(3):271-82. PubMed ID: 17118710
[TBL] [Abstract][Full Text] [Related]
3. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis.
Hirasawa H; Oda S; Nakamura M; Watanabe E; Shiga H; Matsuda K
Blood Purif; 2012; 34(2):164-70. PubMed ID: 23095416
[TBL] [Abstract][Full Text] [Related]
4. Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber.
Hanasawa K; Tani T; Oka T; Yoshioka T; Aoki H; Endo Y; Kodama M
Prog Clin Biol Res; 1988; 264():337-41. PubMed ID: 2837785
[No Abstract] [Full Text] [Related]
5. Clinical effects of polymyxin B-immobilized fiber column in septic patients.
Cruz DN; Bellomo R; Ronco C
Contrib Nephrol; 2007; 156():444-51. PubMed ID: 17464156
[TBL] [Abstract][Full Text] [Related]
6. Selective Polymyxin Hemoperfusion in Complex Therapy of Sepsis in Children after Cardiac Surgery.
Yaroustovsky M; Abramyan M; Rogalskaya E; Komardina E
Blood Purif; 2021; 50(2):222-229. PubMed ID: 33242859
[TBL] [Abstract][Full Text] [Related]
7. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
Naka T; Shinozaki M; Akizawa T; Shima Y; Takaesu H; Nasu H
Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
[TBL] [Abstract][Full Text] [Related]
9. [Effect of continuous blood purification on plasma cytokines in children with severe sepsis].
Yang J; Tian ZF
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):921-3. PubMed ID: 20423880
[TBL] [Abstract][Full Text] [Related]
10. Continuous hemofiltration as blood purification in sepsis.
Bellomo R
New Horiz; 1995 Nov; 3(4):732-7. PubMed ID: 8574604
[TBL] [Abstract][Full Text] [Related]
11. Blood purification for critical illness: cytokines adsorption therapy.
Tsuchida K; Yoshimura R; Nakatani T; Takemoto Y
Ther Apher Dial; 2006 Feb; 10(1):25-31. PubMed ID: 16556133
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin improves fulminant pseudomembranous colitis by reducing the elevated endogenous cannabinoids and inflammatory cytokines: report of a case.
Kimura Y; Sato K; Tokuda H; Hashiguchi T; Maruyama I; Orito E; Dohi Y; Joh T
Hepatogastroenterology; 2008; 55(84):956-8. PubMed ID: 18705306
[TBL] [Abstract][Full Text] [Related]
13. [Adsorption therapy in sepsis].
Hasper D; Schefold JC; Jörres A
Med Klin Intensivmed Notfmed; 2015 May; 110(4):272-7. PubMed ID: 25248547
[TBL] [Abstract][Full Text] [Related]
14. Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome.
Nakamura T; Fujiwara N; Sato E; Kawagoe Y; Ueda Y; Yamada S; Koide H
ASAIO J; 2009; 55(4):395-9. PubMed ID: 19506468
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin).
Shoji H
Ther Apher Dial; 2003 Feb; 7(1):108-14. PubMed ID: 12921125
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal Blood Purification Therapies for Sepsis.
Monard C; Rimmelé T; Ronco C
Blood Purif; 2019; 47 Suppl 3():1-14. PubMed ID: 30974444
[TBL] [Abstract][Full Text] [Related]
17. Effect over time of endotoxin adsorption therapy in sepsis.
Ueno T; Sugino M; Nemoto H; Shoji H; Kakita A; Watanabe M
Ther Apher Dial; 2005 Apr; 9(2):128-36. PubMed ID: 15828924
[TBL] [Abstract][Full Text] [Related]
18. High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs.
Rimmelé T; Assadi A; Cattenoz M; Desebbe O; Lambert C; Boselli E; Goudable J; Etienne J; Chassard D; Bricca G; Allaouchiche B
Nephrol Dial Transplant; 2009 Feb; 24(2):421-7. PubMed ID: 18799607
[TBL] [Abstract][Full Text] [Related]
19. Hemofiltration-absorption systems for the treatment of experimental sepsis: is it possible to remove the "evil humors" responsible for septic shock?
Opal SM
Crit Care Med; 2000 May; 28(5):1681-2. PubMed ID: 10834750
[No Abstract] [Full Text] [Related]
20. Polymyxin-direct hemoperfusion for sepsis-induced multiple organ failure.
Hirabayashi K; Shiohara M; Saito S; Tanaka M; Yanagisawa R; Tsuruta G; Fukuyama T; Hidaka Y; Nakazawa Y; Shimizu T; Sakashita K; Koike K
Pediatr Blood Cancer; 2010 Jul; 55(1):202-5. PubMed ID: 20486188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
